Explains the differences among popular GLP-1 diabetes and weight-loss drugs (Ozempic, Wegovy, Mounjaro, Zepbound) and outlines how coverage works under VA health care and TRICARE. Highlights eligibility, prior-authorization/medical-necessity requirements, and common limits that affect access and out-of-pocket costs for beneficiaries.
Read full story at Military.com →Related Topics
tricareva-healthcareprescription-drugsweight-loss-medicationsglp-1ozempicwegovymounjarozepbound